Colleen Dunn

642 total citations
18 papers, 491 citations indexed

About

Colleen Dunn is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Colleen Dunn has authored 18 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 2 papers in Infectious Diseases. Recurrent topics in Colleen Dunn's work include Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (11 papers) and Asthma and respiratory diseases (7 papers). Colleen Dunn is often cited by papers focused on Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (11 papers) and Asthma and respiratory diseases (7 papers). Colleen Dunn collaborates with scholars based in United States, Ireland and Singapore. Colleen Dunn's co-authors include Zoe Davies, Richard B. Moss, Rabindra Tirouvanziam, Leonore A. Herzenberg, Yaël Gernez, C. Conrad, Leonard A. Herzenberg, Iris Schrijver, Carlos Milla and Jeffrey J. Wine and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Analytical Chemistry.

In The Last Decade

Colleen Dunn

17 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colleen Dunn United States 10 362 98 88 65 53 18 491
François Carlier Belgium 9 193 0.5× 71 0.7× 81 0.9× 81 1.2× 23 0.4× 22 348
Punnam Chander Veerati Australia 10 125 0.3× 97 1.0× 95 1.1× 63 1.0× 34 0.6× 14 319
Akitaka Iwagaki Japan 11 141 0.4× 120 1.2× 73 0.8× 82 1.3× 26 0.5× 20 414
John J. Brewington United States 13 288 0.8× 59 0.6× 35 0.4× 80 1.2× 39 0.7× 29 431
Eswari Dodagatta-Marri United Kingdom 9 163 0.5× 97 1.0× 28 0.3× 53 0.8× 48 0.9× 9 285
William I. Mariencheck United States 7 329 0.9× 95 1.0× 22 0.3× 137 2.1× 13 0.2× 11 485
Anna‐Carla Defilippi Italy 8 160 0.4× 49 0.5× 120 1.4× 46 0.7× 22 0.4× 14 397
Biin Sung United States 10 68 0.2× 65 0.7× 84 1.0× 107 1.6× 36 0.7× 14 320
J.L. Yntema Netherlands 10 146 0.4× 47 0.5× 76 0.9× 43 0.7× 108 2.0× 20 385
Rhiannon B. Werder Australia 14 172 0.5× 228 2.3× 154 1.8× 146 2.2× 80 1.5× 28 554

Countries citing papers authored by Colleen Dunn

Since Specialization
Citations

This map shows the geographic impact of Colleen Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Dunn more than expected).

Fields of papers citing papers by Colleen Dunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Dunn. The network helps show where Colleen Dunn may publish in the future.

Co-authorship network of co-authors of Colleen Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen Dunn. A scholar is included among the top collaborators of Colleen Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen Dunn. Colleen Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Burgener, Elizabeth B., Arya Khosravi, Michelle S. Bach, et al.. (2024). Pf bacteriophage is associated with decline in lung function in a longitudinal cohort of patients with cystic fibrosis and Pseudomonas airway infection. Journal of Cystic Fibrosis. 24(2). 345–352. 1 indexed citations
2.
Malkovskiy, Andrey V., Colleen Dunn, Sean P. Ryan, et al.. (2019). Salivary Thiocyanate as a Biomarker of Cystic Fibrosis Transmembrane Regulator Function. Analytical Chemistry. 91(12). 7929–7934. 8 indexed citations
3.
Dunn, Colleen, et al.. (2018). Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults. Scientific Reports. 8(1). 16233–16233. 5 indexed citations
4.
Dunn, Colleen, et al.. (2017). The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels: Human in vivo measurements. PLoS ONE. 12(4). e0175486–e0175486. 6 indexed citations
5.
Davies, Zoe, et al.. (2017). Ivacaftor restores CFTR-dependent sweat gland fluid secretion in cystic fibrosis subjects with S945L alleles. Journal of Cystic Fibrosis. 17(2). 179–185. 4 indexed citations
6.
Dunn, Colleen, et al.. (2016). Evaporimeter and Bubble-Imaging Measures of Sweat Gland Secretion Rates. PLoS ONE. 11(10). e0165254–e0165254. 16 indexed citations
7.
Gernez, Yaël, Jeffrey Waters, Colleen Dunn, et al.. (2016). Modulatory Effects of Aspergillus Colonization and Abpa on Blood and Sputum Granulocytes in CF. Journal of Allergy and Clinical Immunology. 137(2). AB29–AB29. 1 indexed citations
8.
Gernez, Yaël, Jeffrey Waters, Bojana Mirković, et al.. (2015). Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis. European Respiratory Journal. 47(1). 177–185. 34 indexed citations
9.
Dunn, Colleen, Roham T. Zamanian, Richard D. Bland, et al.. (2014). Late-breaking abstract: A relative plasma elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease. European Respiratory Journal. 44(Suppl 58). P1200–P1200.
10.
Conrad, C., James Lymp, Valeria Thompson, et al.. (2014). Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial. Journal of Cystic Fibrosis. 14(2). 219–227. 80 indexed citations
11.
Cho, Hyung‐Ju, Il‐Ho Park, Jin Hyeok Jeong, et al.. (2014). A Little CFTR Goes a Long Way: CFTR-Dependent Sweat Secretion from G551D and R117H-5T Cystic Fibrosis Subjects Taking Ivacaftor. PLoS ONE. 9(2). e88564–e88564. 46 indexed citations
12.
Wine, Jeffrey J., Jonathan Chen, Colleen Dunn, et al.. (2013). In Vivo Readout of CFTR Function: Ratiometric Measurement of CFTR-Dependent Secretion by Individual, Identifiable Human Sweat Glands. PLoS ONE. 8(10). e77114–e77114. 31 indexed citations
13.
Gernez, Yaël, Colleen Dunn, Karolina Krasinska, et al.. (2012). Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens. Journal of Cystic Fibrosis. 11(6). 502–510. 32 indexed citations
14.
Prais, Dario, et al.. (2012). Assessment of lung function in pre-school children with cystic fibrosis by nitrogen washout. 40. 1844. 1 indexed citations
15.
Laval, Julie, Yaël Gernez, C. Conrad, et al.. (2009). Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proceedings of the National Academy of Sciences. 106(14). 5779–5783. 79 indexed citations
16.
Tirouvanziam, Rabindra, Yaël Gernez, C. Conrad, et al.. (2008). Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proceedings of the National Academy of Sciences. 105(11). 4335–4339. 123 indexed citations
17.
Dunn, Colleen, et al.. (1998). Aerosolized albuterol improves airway reactivity in infants with acute respiratory failure from respiratory syncytial virus. Pediatric Pulmonology. 26(1). 12–20. 11 indexed citations
18.
Stokes, G M, et al.. (1989). Do lung volumes change with sleep state in the neonate?. European Journal of Pediatrics. 148(4). 360–364. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Carlier Breakdown of academic impact, for papers by Punnam Chander Veerati Breakdown of academic impact, for papers by Akitaka Iwagaki Breakdown of academic impact, for papers by John J. Brewington Breakdown of academic impact, for papers by Eswari Dodagatta-Marri Breakdown of academic impact, for papers by William I. Mariencheck Breakdown of academic impact, for papers by Anna‐Carla Defilippi Breakdown of academic impact, for papers by Biin Sung Breakdown of academic impact, for papers by J.L. Yntema Breakdown of academic impact, for papers by Rhiannon B. Werder
Rankless by CCL
2026